A new generation of safety short peripheral IV catheter (SPIVC) technology designed to keep healthcare workers safe from needlestick injuries and blood exposure is now available from BD Medical.
In addition to proven needlestick protection, BD Insyte™ Autoguard™ BC with Blood Control Technology has also been proven to reduce the risk of blood exposure by 95 percent, compared to a non-blood control IV catheter, according to a recently published study.1 The new blood control technology is a septum inside of the catheter hub designed to prevent blood from leaking out during insertion.
During the insertion of SPIVCs, clinicians experience blood leakage nearly 40 percent of the time. The new BD safety catheter is designed to reduce the risk of mucocutaneous blood exposure. Mucocutaneous exposure refers to blood or body fluid exposure to the mucous membrane of the eyes, nose, mouth, or the skin.
For more information, visit www.bd.com .